课题基金 / 基金详情

Functional and Structural Studies of CD74 Activation

Functional and Structural Studies of CD74 Activation
CD74 激活的功能和结构研究
批准号:
7626431
负责人:
ELIAS LOLIS
金额:
$39.41万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2011-05-31
关键词:
AcuteAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntigensApplications GrantsArthritisAutoimmune DiseasesBindingBiologicalBiologyBloodCatalytic DomainCell Surface ReceptorsCell surfaceCellsChronicColitisComplexConsensusCytokine ReceptorsCytoplasmic TailDeletion MutagenesisDependenceDinoprostoneDiseaseDrug Delivery SystemsDrug DesignEarly EndosomeEndoplasmic ReticulumEndosomesEndotoxemiaExposure toExtracellular DomainFDA approvedFactor XGlucocorticoidsGoalsHLA AntigensHistocompatibilityHistocompatibility Antigens Class IIHumanI-kappa B ProteinsImmigrationImmune systemInfectionInflammationInflammatoryInflammatory ResponseLaboratoriesLeadLigationLung InflammationMHC Class II GenesMalignant NeoplasmsMediatingMicrobeMigration Inhibitory FactorMitogen-Activated Protein KinasesMolecularMonoclonal AntibodiesMouse StrainsMutagenesisPTGS2 genePeptidesPharmaceutical PreparationsPhospholipase A2Phosphorylation SitePhysiologicalPreclinical Drug EvaluationProductionProteinsPuncture procedureRecruitment ActivityRegulationResearch PersonnelRoleSentinelSeptic ShockSignal PathwaySignal TransductionSiteSite-Directed MutagenesisStructureT-Cell ReceptorTLR4 geneTP53 geneTertiary Protein StructureTherapeuticTissuesTraumaVesicleX-Ray Crystallographyactivated Protein Cbasecytokinedesigninhibitor/antagonistinvariant chainmacrophagemicrobialmonocytemouse modelpathogenphenylpyruvate tautomeraseprogramsreceptorresearch studysmall moleculethree dimensional structuretoll-like receptor 4tumorigenesisuptake

项目摘要

项目成果

ELIAS LOLIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): CD74 is a cell surface receptor, but is better known as the human histocompatibility leukocyte antigen (HLA) class ll-assoociated invariant chain that transports class II from the endoplasmic reticulum to vesicles which fuse with endosomes. The physiological role for the presence of CD74 on the cell surface is not known. Some experiments show that it is necessary for the rapid uptake of HLA-DR-specific monoclonal antibodies into early endosomes and for peptide loading on the cell surface, but cell-surface CD74 does not always correlate with cell-surface expression of HLA class II molecules. More recently, CD74 has been identified as a cell surface receptor for the cytokine macrophage migration inhibitory factor (MIF). MIF is a pro-inflammatory protein that is secreted by cells upon exposure to microbes or their products. Increased levels of this protein have been shown to mediate lethality in mice models of acute inflammation (endotoxemia) and septic shock (cecal ligation and puncture). Inhibition of MIF shows therapeutic benefits in animal models of arthritis, acute colitis, acute infections, and multiple forms of cancer. In humans, high levels of MIF are associated with these diseases. The hypothesis of this proposal is that CD74 mediates the biological effects of MIF. This proposal aims to (1) examine the requirement for CD74 in various signaling pathways responsible for MIF biology (MAP kinase cytoplasmic PLA2 activation, expression and activation of COX-2, expression of Toll-like receptor 4, counter-regulation of glucocorticoid anti-inflammatory effects, inhibition of p53), (2) characterize any potential relationship between the MIF catalytic site and CD74 binding, (3) characterize the three dimensional structure of the complex between MIF and the ectodomain of CD74 (sCD74), and (4) use site-directed and structure-based mutagenesis to determine residues on MIF and CD74 that are important for binding and/or signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Humanizing CXCL13 and CXCR5 in mice
  • 批准号:
    10542831
  • 项目类别:
  • 资助金额:
    $19.19万
  • 财政年份:
    2022
  • 负责人:
    ELIAS LOLIS
  • 依托单位:
Humanizing CXCL13 and CXCR5 in mice
  • 批准号:
    10357214
  • 项目类别:
  • 资助金额:
    $23.49万
  • 财政年份:
    2022
  • 负责人:
    ELIAS LOLIS
  • 依托单位:
Structure of the Chemokine Receptor CXCR3
  • 批准号:
    8773139
  • 项目类别:
  • 资助金额:
    $24.98万
  • 财政年份:
    2014
  • 负责人:
    ELIAS LOLIS
  • 依托单位:
Structure of the Chemokine Receptor CXCR3
  • 批准号:
    8874106
  • 项目类别:
  • 资助金额:
    $20.81万
  • 财政年份:
    2014
  • 负责人:
    ELIAS LOLIS
  • 依托单位:
海外基金